T

Tecon Biology Co Ltd
SZSE:002100

Watchlist Manager
Tecon Biology Co Ltd
SZSE:002100
Watchlist
Price: 6.38 CNY 0.79% Market Closed
Market Cap: 8.7B CNY

Intrinsic Value

The intrinsic value of one Tecon Biology Co Ltd stock under the Base Case scenario is 9.67 CNY. Compared to the current market price of 6.38 CNY, Tecon Biology Co Ltd is Undervalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
9.67 CNY
Undervaluation 34%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation History
Tecon Biology Co Ltd

Tecon Biology Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Tecon Biology Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Tecon Biology Co Ltd
SZSE:002100
CN
Food Products
Market Cap
8.7B CNY
IPO
Dec 26, 2006
CN
Food Products
Market Cap
8.7B CNY
IPO
Dec 26, 2006
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Tecon Biology Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Tecon Biology Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tecon Biology Co Ltd

Current Assets 9.1B
Cash & Short-Term Investments 3.7B
Receivables 1.1B
Other Current Assets 4.3B
Non-Current Assets 7.8B
Long-Term Investments 33.6m
PP&E 7.1B
Intangibles 571.3m
Other Non-Current Assets 140.4m
Efficiency

Free Cash Flow Analysis
Tecon Biology Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tecon Biology Co Ltd

Revenue
17.4B CNY
Cost of Revenue
-15.9B CNY
Gross Profit
1.5B CNY
Operating Expenses
-1.6B CNY
Operating Income
-173.1m CNY
Other Expenses
-120.2m CNY
Net Income
-293.3m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tecon Biology Co Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
37/100
Profitability
Score

Tecon Biology Co Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tecon Biology Co Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
52/100
Solvency
Score

Tecon Biology Co Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tecon Biology Co Ltd

Wall Street analysts forecast Tecon Biology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tecon Biology Co Ltd is 8.54 CNY with a low forecast of 7.17 CNY and a high forecast of 10.5 CNY.

Lowest
Price Target
7.17 CNY
12% Upside
Average
Price Target
8.54 CNY
34% Upside
Highest
Price Target
10.5 CNY
65% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tecon Biology Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Tecon Biology Co Ltd stock?

The intrinsic value of one Tecon Biology Co Ltd stock under the Base Case scenario is 9.67 CNY.

Is Tecon Biology Co Ltd stock undervalued or overvalued?

Compared to the current market price of 6.38 CNY, Tecon Biology Co Ltd is Undervalued by 34%.

Back to Top